Putnam Investments LLC Has $993,000 Stake in NextGen Healthcare, Inc. (NASDAQ:NXGN)

Putnam Investments LLC trimmed its holdings in shares of NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) by 1.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,112 shares of the company’s stock after selling 1,009 shares during the period. Putnam Investments LLC owned 0.08% of NextGen Healthcare worth $993,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Clearstead Advisors LLC acquired a new stake in NextGen Healthcare during the 2nd quarter valued at $26,000. Point72 Hong Kong Ltd acquired a new stake in shares of NextGen Healthcare in the 3rd quarter valued at $40,000. Captrust Financial Advisors increased its stake in shares of NextGen Healthcare by 61.5% in the 1st quarter. Captrust Financial Advisors now owns 4,255 shares of the company’s stock valued at $89,000 after buying an additional 1,620 shares during the period. UBS Group AG increased its stake in shares of NextGen Healthcare by 211.1% in the 3rd quarter. UBS Group AG now owns 6,639 shares of the company’s stock valued at $118,000 after buying an additional 4,505 shares during the period. Finally, DCM Advisors LLC acquired a new stake in shares of NextGen Healthcare in the 2nd quarter valued at $183,000. 73.70% of the stock is owned by institutional investors and hedge funds.

NextGen Healthcare Stock Down 2.0 %

NASDAQ:NXGN opened at $16.85 on Tuesday. NextGen Healthcare, Inc. has a 12-month low of $16.13 and a 12-month high of $21.99. The company has a quick ratio of 2.53, a current ratio of 2.53 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $1.11 billion, a P/E ratio of 48.14 and a beta of 1.03. The stock’s fifty day simple moving average is $18.22 and its 200-day simple moving average is $18.49.

Analysts Set New Price Targets

Separately, StockNews.com cut NextGen Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Friday, January 20th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, NextGen Healthcare presently has an average rating of “Moderate Buy” and an average target price of $22.75.

NextGen Healthcare Company Profile

(Get Rating)

NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.